中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2011年
3期
175-179
,共5页
何仕诚%滕皋军%方文%邓钢%郭金和%朱光宇%李国昭
何仕誠%滕皋軍%方文%鄧鋼%郭金和%硃光宇%李國昭
하사성%등고군%방문%산강%곽금화%주광우%리국소
椎体转移性肿瘤%动脉栓塞化疗%椎体成形术%骨水泥
椎體轉移性腫瘤%動脈栓塞化療%椎體成形術%骨水泥
추체전이성종류%동맥전새화료%추체성형술%골수니
Spinal metastasis%Transarterial chemoembolization%Vertebroplasty%Polymethylmethacrylate
目的 探讨经皮椎体成形术(PVP)联合动脉栓塞化疗术治疗复杂性脊柱转移肿瘤的疗效和安全性.方法 收集2003年3月至2009年12月东南大学附属中大医院内科放化疗后疼痛无缓解的复杂性脊椎转移肿瘤患者49例共72节,背部疼痛评价多为重度,其中合并下肢放射痛17例、双下肢不同程度瘫痪6例.选择性椎体动脉栓塞化疗术后6 d内行PVP,PVP后3 d内CT复查观察PMMA分布及渗漏情况,采用VAS评分及WHO疼痛标准评价疗效,定期随访.结果 双侧椎体动脉选择性插管有44例65节,仅选择人单侧有5例7节.用碘化油1~2 ml+明胶海绵颗粒栓塞29节,单纯用明胶海绵颗粒栓塞41节,单纯灌注化疗2节.平均注入PMMA胸椎4.23 ml,腰椎5.39 ml.联合治疗后3个月CR 21例(42.9%)、PR 22例(44.9%)、MR及NR6例(12.2%),总有效率87.8%.CT证实12例椎体周围PMMA渗漏16节,均无临床症状,无其他严重并发症发生.结论 椎体动脉栓塞化疗和PVP都是脊椎转移性肿瘤的有效治疗手段,二者联合可显著提高椎体合并附件及椎旁转移肿瘤患者的疗效.
目的 探討經皮椎體成形術(PVP)聯閤動脈栓塞化療術治療複雜性脊柱轉移腫瘤的療效和安全性.方法 收集2003年3月至2009年12月東南大學附屬中大醫院內科放化療後疼痛無緩解的複雜性脊椎轉移腫瘤患者49例共72節,揹部疼痛評價多為重度,其中閤併下肢放射痛17例、雙下肢不同程度癱瘓6例.選擇性椎體動脈栓塞化療術後6 d內行PVP,PVP後3 d內CT複查觀察PMMA分佈及滲漏情況,採用VAS評分及WHO疼痛標準評價療效,定期隨訪.結果 雙側椎體動脈選擇性插管有44例65節,僅選擇人單側有5例7節.用碘化油1~2 ml+明膠海綿顆粒栓塞29節,單純用明膠海綿顆粒栓塞41節,單純灌註化療2節.平均註入PMMA胸椎4.23 ml,腰椎5.39 ml.聯閤治療後3箇月CR 21例(42.9%)、PR 22例(44.9%)、MR及NR6例(12.2%),總有效率87.8%.CT證實12例椎體週圍PMMA滲漏16節,均無臨床癥狀,無其他嚴重併髮癥髮生.結論 椎體動脈栓塞化療和PVP都是脊椎轉移性腫瘤的有效治療手段,二者聯閤可顯著提高椎體閤併附件及椎徬轉移腫瘤患者的療效.
목적 탐토경피추체성형술(PVP)연합동맥전새화료술치료복잡성척주전이종류적료효화안전성.방법 수집2003년3월지2009년12월동남대학부속중대의원내과방화료후동통무완해적복잡성척추전이종류환자49례공72절,배부동통평개다위중도,기중합병하지방사통17례、쌍하지불동정도탄탄6례.선택성추체동맥전새화료술후6 d내행PVP,PVP후3 d내CT복사관찰PMMA분포급삼루정황,채용VAS평분급WHO동통표준평개료효,정기수방.결과 쌍측추체동맥선택성삽관유44례65절,부선택인단측유5례7절.용전화유1~2 ml+명효해면과립전새29절,단순용명효해면과립전새41절,단순관주화료2절.평균주입PMMA흉추4.23 ml,요추5.39 ml.연합치료후3개월CR 21례(42.9%)、PR 22례(44.9%)、MR급NR6례(12.2%),총유효솔87.8%.CT증실12례추체주위PMMA삼루16절,균무림상증상,무기타엄중병발증발생.결론 추체동맥전새화료화PVP도시척추전이성종류적유효치료수단,이자연합가현저제고추체합병부건급추방전이종류환자적료효.
Objective To evaluate the efficacy and safety of combining transarterial chemoembolization and percutaneous vertebroplasty (PVP) in the treatment of vertebral and paravertebral metastatic tumors. Methods A retrospective review was conducted in 49 patients with severer painful tumor metastasis in 72 vertebrae and paravertebral tissue who had failed noninvasive treatment at our institution from March 2003 to December 2009. Among them, there were intractable radicular pain ( n = 17) and slight or no motor and sensory function ( n = 6). All patients under transarterial chemoembolization were followed within 6 days by PVP. Computed tomography (CT) was performed within 3 days after PVP to observe the distribution of PMMA ( para-methoxymethamphetamine ) in vertebrae and whether or not there was any leakage. The efficacy was assessed by the change of pain level after combined treatment. Results Bilateral vertebral arteries were selected in 44 cases with 65 vertebrae. And only unilateral vertebral artery was selected in 5 cases with 7 vertebrae. Except for 2 vertebrae with simple artery infusion, 29 vertebrae were embolized by 1-2 ml of lipiodolization and gelfoam particles and 41 vertebrae by gelatine particles. And an average volume of 4. 23 ml and 5.39 ml was injected in each thoracic and lumbar vertebra respectively. The rate of efficacy was at 87. 8% within 3 months after combined therapy. There were CR( complete response)21cases (42. 9% ), PR (partial response) 22 cases(44.9%)and MR/NR (minimal/no response) 6 cases (12. 2% ). No serious complication related to the technique occurred. Only 12 cases with asympotomatic PMMA leakage around 16 vertebrae were demonstrated on post-operative CT. Conclusion Transarterial chemoembolization plus PVP is an effective and safe procedure in the treatment of severe painful vertebral and paravertebral metastatic tumors.